These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 29574212)

  • 1. Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2018 Jul; 23(7):1396-1406. PubMed ID: 29574212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Protocol to Use Comparative Binding Energy Analysis to Estimate Drug-Target Residence Time.
    Ganotra GK; Nunes-Alves A; Wade RC
    Methods Mol Biol; 2021; 2266():171-186. PubMed ID: 33759127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches for computing ligand-receptor binding kinetics.
    Bruce NJ; Ganotra GK; Kokh DB; Sadiq SK; Wade RC
    Curr Opin Struct Biol; 2018 Apr; 49():1-10. PubMed ID: 29132080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward High-Throughput Predictive Modeling of Protein Binding/Unbinding Kinetics.
    Chiu SH; Xie L
    J Chem Inf Model; 2016 Jun; 56(6):1164-74. PubMed ID: 27159844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategies.
    Deganutti G; Moro S
    Future Med Chem; 2017 Apr; 9(5):507-523. PubMed ID: 28362130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Protein-Ligand Interactions: Mechanisms, Models, and Methods.
    Du X; Li Y; Xia YL; Ai SM; Liang J; Sang P; Ji XL; Liu SQ
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based computational analysis of protein binding sites for function and druggability prediction.
    Nisius B; Sha F; Gohlke H
    J Biotechnol; 2012 Jun; 159(3):123-34. PubMed ID: 22197384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds.
    Stoll F; Göller AH; Hillisch A
    Drug Discov Today; 2011 Jun; 16(11-12):530-8. PubMed ID: 21554979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics.
    Lu H; Iuliano JN; Tonge PJ
    Curr Opin Chem Biol; 2018 Jun; 44():101-109. PubMed ID: 29986213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Approaches to the Chemical Equilibrium Constant in Protein-ligand Binding.
    Montalvo-Acosta JJ; Cecchini M
    Mol Inform; 2016 Dec; 35(11-12):555-567. PubMed ID: 27554325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent spectral hypergraph based machine learning (PSH-ML) for protein-ligand binding affinity prediction.
    Liu X; Feng H; Wu J; Xia K
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33837771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational methodologies for compound database searching that utilize experimental protein-ligand interaction information.
    Tan L; Batista J; Bajorath J
    Chem Biol Drug Des; 2010 Sep; 76(3):191-200. PubMed ID: 20636330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Project ranks billions of drug interactions.
    Reardon S
    Nature; 2013 Nov; 503(7477):449-50. PubMed ID: 24284710
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward a robust search method for the protein-drug docking problem.
    Sadjad BS; Zsoldos Z
    IEEE/ACM Trans Comput Biol Bioinform; 2011; 8(4):1120-33. PubMed ID: 20714029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Strategy Revealing the Structural Determinant of Ligand Selectivity towards Highly Similar Protein Targets.
    Wang H; Gao Y; Wang J; Cheng M
    Curr Drug Targets; 2020; 21(1):76-88. PubMed ID: 31556854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capturing structure-activity relationships from chemogenomic spaces.
    Wendt B; Uhrig U; Bös F
    J Chem Inf Model; 2011 Apr; 51(4):843-51. PubMed ID: 21410249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of absolute protein-ligand binding constants with the molecular dynamics free energy perturbation method.
    Woo HJ
    Methods Mol Biol; 2008; 443():109-20. PubMed ID: 18446284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.